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SUMMARY
Neuronsobtaineddirectlyfromhumansomaticcellsholdgreatpromisefordiseasemodelinganddrugscreening.Availableprotocolsrely
on overexpression of transcription factors using integrative vectors and are often slow, complex, and inefﬁcient. We report a fast and
efﬁcient approach for generating induced neural cells (iNCs) directly from human hematopoietic cells using Sendai virus. Upon SOX2
andc-MYCexpression,CD133-positivecordbloodcellsrapidlyadoptaneuroepithelialmorphologyandexhibithighexpansioncapacity.
Under deﬁned neurogenic culture conditions, they express mature neuronal markers and ﬁre spontaneous action potentials that can be
modulated with neurotransmitters. SOX2 and c-MYC are also sufﬁcient to convert peripheral blood mononuclear cells into iNCs. How-
ever, the conversion process is less efﬁcient and resulting iNCs have limited expansion capacity and electrophysiological activity upon
differentiation.OurstudydemonstratesrapidandefﬁcientgenerationofiNCsfromhematopoieticcellswhileunderscoringtheimpactof
target cells on conversion efﬁciency.
INTRODUCTION
Cellular reprogramming has opened new avenues to inves-
tigate human disease and identify potential targets for drug
discovery (Bellin et al., 2012). This technology is particu-
larly useful for cell types in which the target tissue is not
accessible, like the brain. It is now possible to differentiate
human embryonic stem (hES) and human-induced plurip-
otent stem (hiPS) cells into different types of neurons (Hu
et al., 2010; Qiang et al., 2014; Velasco et al., 2014; Zhang
et al., 2013). However, the generation of neuronal cells
from pluripotent stem cells involves long and complex
protocols with problematic variability. Alternatively, direct
lineage conversion (or transdifferentiation) of somatic cells
into neurons (induced neurons [iNs]) has been achieved by
forced expression of lineage-speciﬁc transcription factors
and microRNAs (miRNA) (Ambasudhan et al., 2011;
Caiazzo et al., 2011; Pang et al., 2011; Pﬁsterer et al.,
2011; Vierbuchen et al., 2010; Yoo et al., 2011). Using
this approach, several cell types (Giorgetti et al., 2012;
Karow et al., 2012; Marro et al., 2011) have been converted
intofunctionalneuronsinvitroandalsoinvivo(Guoetal.,
2014; Su et al., 2014; Torper et al., 2013). However, for de-
livery of exogenous reprogramming factors, most available
protocols have used integrative viral vectors, and the con-
version process was rather inefﬁcient. Only recently, non-
integrative methods based on Sendai virus (SeV) or chemi-
cally deﬁned culture conditions have been described for
the direct conversion of nonhuman cells into neural pro-
genitor cells (iNPCs) (Cheng et al., 2014; Lu et al., 2013).
Here, we investigated whether a similar nonintegrative
strategy is applicable for the conversion of human hemato-
poietic cells directly into neurons. Importantly, peripheral
blood (PB), which is routinely used in medical diagnoses,
represents a noninvasive and easily accessible source of
cells for reprogramming both healthy donor and disease-
speciﬁcpatientcells.Basedonourpreviousstudy(Giorgetti
et al., 2012), we chose SOX2 and c-MYC SeV vectors to
reprogram CD133-positive cord blood (CB) cells and adult
PB mononuclear cells (PB-MNCs). We found that the over-
expression of SOX2 and c-MYC by SeV accelerated and
increased the efﬁciency of neural conversion of CD133-
positive CB cells (CB-iNCs) when compared with retroviral
vectors. SOX2 and c-MYC were also sufﬁcient to convert
PB-MNCs into neuronal-like cells (PB-iNCs). However,
compared with CB-iNCs, the process was less efﬁcient,
1118 Stem Cell Reports j Vol. 3 j 1118–1131 j December 9, 2014 j ª2014 The Authorsand the resulting PB-iNCs showed limited expansion, dif-
ferentiationcapacity,andfunctionalproperties.Ourresults
demonstrate the feasibility for rapid and efﬁcient genera-
tion of iNCs from CD133-positive CB cells using noninte-
grative SeV while underscoring the impact of target cell
developmental stage on the reprogramming process for
lineage conversion.
RESULTS
Rapid and Efﬁcient Generation of iNCs from
CD133-Positive CB Cells
We ﬁrst tested whether the forced expression of SOX2
and c-MYC by SeV can induce the conversion of CD133-
positive CB cells directly into neural cells (iNCs); 50,000
magnetic activated cell sorting-isolated CD133-positive
CB cells (purity >95%; data not shown) were infected at a
low multiplicity of infection (MOI) (<5 MOI, infection efﬁ-
ciency 80%–85%; data not shown) and cocultured on irra-
diated ratprimary astrocytes inthepresence ofN2medium
containingbonemorphogeneticprotein(BMP),transform-
ing growth factor b (TGF-b), and glycogen synthase kinase-
3b (GSK-3b) inhibitors (Ladewig et al., 2012)( Figure 1A).
Overexpression of SOX2 and c-MYC by SeVrapidly induced
the acquisition of neuroepithelial morphology in CD133-
positive CB cells (Figure 1Ba–c). After removal of inhibitors
(day 10), reprogrammed cells showed a high expansion ca-
pacity, acquired an immature neural morphology (day 15;
Figure 1Bd), and progressively formed a neural network.
By day 30, CB-iNCs displayed a more complex cytoarchi-
tecture with long processes and elaborated branching,
preferentially organized into clusters, with persistence of
proliferating cores (Figure 1Be).
Immunostaining showed that by day 15 most cells were
positive for SOX2, and some of them already expressed
beta-III tubulin (TUJ1) (Figure 1Ca). By day 30, the cells
were organized in clusters that expressed TUJ1 and
were interconnected by microtubule-associated protein 2
(MAP2)-positive ﬁbers (Figure 1Cb–d); there were some
PAX6-positive cells within the clusters (indicated by white
arrows; Figure 1Cc). Quantitative analysis revealed that af-
ter 30 days of neural induction a majority of HUNU cells
were positive for TUJ1 ( 80%, n[HUNU cells] = 17,330;
two independent experiments) (Figures S1A and S1B avail-
able online) and around 50% (n[HUNU cells] = 24,362)
were positive for MAP2 (Figure S1C). Moreover, ﬂuores-
cence-activated cell sorting (FACS) analysis revealed that
over 25% of cells were neural cell adhesion molecule
(N-CAM)-positive after 15 days of induction ( 20 million
N-CAM-positive cells at day 15; Figures 1D and 1E), and
the proportion of N-CAM-positive cells progressively
increased over time ( 60 million at day 45, Figures 1D
and1E).Ontheotherhand,thelossofCD45,ahematopoi-
etic speciﬁc antigen, along with the downregulation of
b2-microglobulin (B2M) indicated thatreprogrammed cells
had lost their hematopoietic identity (Figures 1D and S1D).
Importantly, the emergence of CB-iNCs was accompanied
by activation of endogenous SOX2 (82-fold at day 10; Fig-
ure 1F), whereas expression of other pluripotency-related
genessuchasOCT4,NANOG,CRIPTO,REX1,andDNMT3B
(Figure 1G), as well as endodermal/mesodermal-speciﬁc
transcription factors (GATA4 and BRACHYURY; data not
shown), was never detected throughout the conversion
process. Likewise, analysis of TRA-1-60 at different time
points by FACS analysis showed no positive cells during
the conversion process (Figure S1E). These results were
consistent in ﬁve independent experiments (i.e., ﬁve CB
units), demonstrating the reproducibility of this reprog-
ramming strategy.
A more extensive quantitative RT-PCR (qRT-PCR) anal-
ysis of CB-iNCs conﬁrmed a remarkable upregulation of
TUJ1, doublecortin (DCX), and MAP2 already at 15 days af-
ter neural induction, whereas PAX6 and early neural
markers (MUSASHI, SOX1, and NESTIN) were present at
lower levels (Figure 2A). While recent work identiﬁed
MASH1 as the most important driver of neural conversion
in ﬁbroblasts (Chanda et al., 2014), we observed only mar-
ginal induction of MASH1 expression in CB-iNCs (Fig-
ure 2A). In contrast, BRN2 was progressively activated in
CB-iNCs during the neural conversion (Figure 2A), suggest-
ing an involvement of BRN2 in this process, in line with
other recent reports (Lujan et al., 2012; Zou et al., 2014).
At this stage, there was little or no expression of mature
postmitotic neuronal markers such as NEUN (RBFOX-3), ve-
sicularglutamatetransporter1(vGLUT1/SLC17A7),andTAU
(MAPT)(Figure2A).CB-iNCsmaintainedthismolecularpro-
ﬁle during their propagation (days 15 to 45), when the cells
were cultured in the presence of N2 + B27 with ﬁbroblast
growth factor 2 (FGF2) and brain-derived neurotrophic fac-
tor (BDNF). These data suggest that the conversion process
rapidly activates a transcriptional proﬁle characteristic of
committed neuroblasts and early neural progenitors.
CB-iNCs Are Expandable and Differentiate into
Functional Neurons In Vitro
To conﬁrm the presence of an expandable neural progeni-
tor population, CB-iNCs were disaggregated as single
cells and were seeded on matrigel in the presence of N2
media containing FGF2. Under these culture conditions,
CB-iNCs displayed neuroepithelial morphology within
1 week (Figure 2Ba) and expressed the early neural marker
NESTIN (Figure 2Bb). qRT-PCR analysis also showed upre-
gulation of mRNA levels of early neural progenitor markers
(NESTIN, MUSASHI, and SOX1) and concomitant downre-
gulation of neural committed markers (PAX6, TUJ1, DCX,
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iNCscouldbefrozenandthawedandpropagatedinculture
for >60 passages while maintaining their neural phenotype
and chromosomal stability (Figures S2A and S2B). These
data strongly suggest that overexpression of SOX2 and c-
MYC combined with permissive culture conditions drives
thedirect conversionof CD133-positive CB cellsinto a het-
erogeneous neural cell population reminiscent of adult
neural stem cells present in neurogenic niches (Codega
et al., 2014). Long-term propagated CB-iNCs showed
persistent expression of SeV, which was completely elimi-
nated only after temperature treatment (Figure 2D).
We next assessed the differentiation potential of CB-
iNCs. For this purpose, they were dissociated into single
cells and replated on irradiated rat astrocytes in the pres-
ence of neural differentiation medium (Figure 1A). After
35 days under differentiation conditions, CB-iNCs dis-
played extensive arborization (Figure 3Aa) and expressed
axonal neuroﬁlament SMI 312 (NF) (Figure 3Ab). More-
over,TAU-positiveneuronsshowedappropriatedownregu-
lationofSOX2nuclearexpression,andMAP2/TAUsegrega-
tion was observed into different subcellular compartments
(dendrites andaxons, respectively; Figure 3Ac andd).Some
cellsalsoexpressedNEUN (RBFOX-3),indicative ofpostmi-
totic mature neurons (Figure 3Ae). In these culture condi-
tions, about 17% of cells (n[cells] = 409) were found to be
immunopositive for gamma-aminobutyric acid (GABA)
(Figure 3Ae) and 47% (n[cells] = 1442) for vGLUT1 (Fig-
ure 3Af). Finally, mature CB-iNCs expressed synaptic pro-
teins as indicated by the expression of Synapsin1 (SYN)
and Synaptic vesicle protein 2 (SV2) (Figure 3Ag–i). Other
markers corresponding to monoamine transmitter pheno-
types such as tyrosine hydroxylase (for dopamine and
noradrenergic neurons) and serotonin were not expressed
(data not shown). Nonetheless, we cannot exclude that
CB-iNCs upon more speciﬁc condition culture could differ-
entiate into other neuronal phenotypes. Likewise, under
these conditions, astrocytic and oligodendrocitic markers
were not detected, but glial ﬁbrillary acidic protein
(GFAP)-positive cells could be generated when cultured in
the presence of epidermal growth factor and fetal bovine
serum (data not shown).
We next examined the electrophysiological properties of
CB-iNCs using whole-cell recordings. Mature neurons were
visualized by transduction with the SYN::GFP reporter.
Both inward Na
+ and outward K
+ voltage-dependent cur-
rents were reliably evoked by depolarizing voltage steps
from a holding potential of  50 mV (data not shown; Fig-
uresS3AandS3B). Singleormultipleactionpotentialswere
triggered by injection of depolarizing current steps in 15 of
37 cells (Figures 3B and 3C). Moreover, 60% of these active
cells (9 of 15 cells) showed spontaneous action potentials
(Figure 3B). Firing rate was increased upon glutamate appli-
cation (100 mM) and completely inhibited when a-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
and N-methyl-D-aspartate (NMDA) glutamate receptor an-
tagonists were simultaneously perfused (50 mM DNQX and
50 mM MK801) (Figure 3C). In another experiment (Fig-
ure S3C), bath perfusion of glutamate (200 mM) induced
an inward current of 37.53 ± 13 pA (n = 5 of 9) that
was completely reversed by the AMPA receptor antago-
nist DNQX (50 mM). Consistently, immunostaining of
recorded cells showed expression of vGLUT1 (Figure 3C).
Furthermore, in some cells, the spontaneous ﬁring rate
Figure 1. Generation of iNCs from CD133-Positive CB Cells Using SeV Vectors
(A) Schematic timeline of neural conversion. CD133-positive CB cells transduced with SOX2 and c-MYC SeV vectors were seeded on irra-
diated rat astrocytes and cultured with N2 medium supplemented with LDN, CHIR99021, and SB431542 compounds for 10 days. From days
10 to 30, cells were cultured in N2 + B27 medium. From day 30 onward, CB-iNCs were terminally differentiated in the presence of N2 + B27
medium with BDNF, GDNF, RA, and dbcAMP. Electrophysiology was performed at day 65.
(B) Representative phase-contrast images illustrating the morphological conversion of CD133-positive CB cells into iNCs. Note that cells
with neural progenitor morphology were identiﬁable already at day 7 (n = 5 independent experiments). Scale bars are as indicated in the
panels.
(C) Representative immunoﬂuorescence images of CB-iNCs at days 15 and 30. Two weeks after induction, CB-iNCs were SOX2 positive and
TUJ1 positive and exhibited a neural morphology (a). By day 30, CB-iNCs showed a more complex cytoarchitecture, organized in clusters
with long TUJ1- and MAP2-positive processes (b–d). Of note, few PAX6-positive cells (white arrows) were observed (c). Scale bars are as
indicated in the panels.
(D) Flow cytometry quantiﬁcation of CD45 and CD56 (N-CAM) in a representative experiment, showing the progressive increase in N-CAM-
positive cells reaching  60% by day 45.
(E) Quantiﬁcation of total cell number and N-CAM-positive neuronal cells at differentiation days 15, 30, and 45.
(F)QuantiﬁcationofendogenousSOX2mRNAlevelsinCB-iNCsbyqRT-PCRanalysis.DataareshownasfoldinductionofSOX2mRNAlevelin
CB-iNCs relative to CD133-positive CB cells, which is considered as 1. Human total brain RNA (YORBIO) was used as positive control. Data
are represented as mean ± SD (n = 3 independent experiments).
(G) Pluripotency genes (OCT4, NANOG, REX1, CRIPTO, and DNMT3B) expression was not detected in CB-iNCs by qRT-PCR during the con-
version process. CB derived iPSCs were used as positive control. Data are represented as mean ± SD (n = 3 independent experiments).
See also Figure S1.
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from CD133-Positive CB Cells
(A) Quantiﬁcation of expression levels by
qRT-PCR of a panel of early, immature, and
mature neuronal markers in CD133-positive
CB cells and CB-iNCs at 15, 30, and 45 days
of neural induction and propagation. Data
are represented as mean ± SD (n = 3 inde-
pendent experiments). Expression of these
genes was not detected in untransduced
CD133-positive CB cells.
(B) Representative phase-contrast live im-
age (a) and immunostaining (b) of CB-iNCs
at passage 5 cultured on matrigel in the
presence of FGF2. CB-iNCs acquired a neural
epithelial-like morphology and expressed
early neural progenitor markers such as
NESTIN and SOX2. The scale bar is as indi-
cated in the panels.
(C) qRT-PCR analysis showing transcrip-
tional changes in the CB-iNCs propagated
on matrigel in the presence of FGF2 for ﬁve
passages relative to CB-iNCs at day 30 of
neural induction. Data are represented as
mean ± SD (n = 3 independent experi-
ments).
(D) SeV vectors analyzed by qRT-PCR after
20 passages before and after temperature
treatment (39 C)-mediated silencing. Data
are represented as mean ± SD (n = 3 inde-
pendent experiments).
See also Figure S2.
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ure S3D). There were signiﬁcant differences in the intrinsic
electrophysiological properties—membrane capacitance,
membrane resistance, and resting membrane potential—
between the spontaneously active and nonactive cells
(Figure 3D). Indeed, in the spontaneously active cells, the
membrane capacitance was larger and the resting mem-
brane potentials less depolarized than those recorded
from nonactive cells, suggesting that spontaneously active
cells were more mature (Johnson et al., 2007). Importantly,
CB-iNCs frozen and thawed could also be differentiated
into mature neurons that displayed spontaneous electrical
activity (Figure S3E). Taken together, our data show that
CB-iNCs generated by expression of SOX2 and c-MYC SeV
are expandable and have the potential to differentiate
in vitro into electrophysiological active cells.
iNCs Generated from PB-MNCs Displayed Low
Expansion Capacity and Limited Electrophysiological
Activity
PB would be a highly amenable source for reprogramming
patient-speciﬁc cells. Thus, we next investigated the possi-
bilityofconvertingPB-MNCsintoiNCsusingthesameSeV
strategy. For this purpose, 250,000 MNCs (n = 4) were in-
fected at high MOI (ten and ﬁve for SOX2 and c-MYC,
respectively) and cocultured on irradiated rat astrocytes
in the presence of N2 medium with BMP, TGF-b, and
GSK-3b inhibitors (Figure 4A). As shown in Figure 4B,
morphological changes in PB-MNCs were similar to those
observed in CD133-positive CB cells. Immunostaining
showed that within 15 days of induction, PB-iNCs stained
forDCX(Figure4Ca).However,theconversionprocesswas
slower and less efﬁcient, and the resulting iNCs showed
a lower expansion capacity. In fact PB-iNCs could not be
maintained in culture for more than six passages, and
only a few cells within the culture were positive for Ki67
(Figure 4Cb). By day 30, PB-iNCs acquired a more mature
morphology and expressed markers indicating neuronal
commitment(includingTUJ1,MAP2,andNF),asindicated
by immunostaining and qRT-PCR analysis (Figures 4Cc–e
and 4D). After 30 days of induction, about 16% (n[cells] =
252) of the cells were positive for TUJ1, and 9% (n[cells] =
158) were positive for MAP2.
As described for CB-iNCs, PB-iNCs were also transduced
with SYN::GFP reporter lentivirus and cocultured on irradi-
atedratastrocytesduring6–8weeksforneuronaldifferenti-
ation and whole-cell recordings (Figure 4E). These PB-iNCs
displayed inward Na
+ and outward K+ voltage-dependent
currents (n = 15) (Figure 4F) and were able to ﬁre single
and multiple action potentials following injection of depo-
larizing current steps (n = 7) (Figure 4G). However, they did
not show spontaneous activity or response to glutamate
application (n = 4) (Figure 4H). Intrinsic electrophysiolog-
ical properties such as membrane capacitance (23.29 ±
2.9 pF) and resting membrane potential ( 29.0 ± 4.0 mV),
butnotmembraneresistance(1,174±156MU),weresignif-
icantly different from those recorded in spontaneously
active CB-iNCs (see Figure 3D).
Recently, it has been demonstrated that upregulation of
p16
Ink4aandp19
Arfinducescellularsenescenceinadultcells
that may represent a roadblock for the direct conversion of
human ﬁbroblasts into functional neurons (Sun et al.,
2014). In line with these ﬁndings, we observed that
p16
Ink4a and p19
Arf mRNA levels were signiﬁcantly higher
in PB-MNCs than in CD133-positive CB cells (Figure S4A).
Conversely, telomerase reverse transcriptase (hTERT),
which prevents cellular senescence, was higher in
CD133-positive CB cells than in PB-MNCs (Figure S4B).
These data are in agreement with the hypothesis that regu-
lationofsenescencemightrepresentakeystepinthedirect
conversion of somatic cells into neurons and raise the pos-
sibility that p16
Ink4a and p19
Arf can be targeted to improve
neural reprogramming of PB-MNCs in future studies.
DISCUSSION
Direct reprogramming of human somatic cells into
functional neurons has been proposed as an alternative
strategy to obtain patient-speciﬁc neurons for disease
modeling, drug screening, and toxicity tests (Qiang
et al., 2014). Indeed, this approach offers some advantages
as compared with classic reprogramming to hiPSCs and
redifferentiation, notably in time and experimental
variability. However, available protocols for generating
expandable neural populations rely on the use of mouse
cells and do not support the generation of human neurons
on a large scale (Cheng et al., 2014; Han et al., 2012; Lujan
et al., 2012; Ring et al., 2012; Thier et al., 2012). In the pre-
sent study, we report a rapid and efﬁcient approach to
obtain iNCs from human hematopoietic cells using SeV.
Compared with retroviral and lentiviral-based approach,
SeV is more efﬁcient for gene delivery to hematopoietic
cells and has been used to generate blood-derived, integra-
tion-free hiPSCs (Ban et al., 2011). Here, we successfully
obtained iNCs from CD133-positive CB cells in less than
1 week by coexpression of SOX2 and c-MYC SeV. The
highly proliferative nature of CD133-positive CB cells
during the ﬁrst week of the reprogramming process
made difﬁcult to accurately determine the efﬁciency of
CB-iNCs. Nevertheless, the yield of CB-iNCs was really
remarkable as infection of 50,000 CD133-positive CB cells
resulted in over 20 million of N-CAM-positive cells 2 weeks
later. Moreover, CB-iNCs could be cryopreserved, propa-
gated, and further expanded for >60 passages without
losing their functional properties. Upon differentiation,
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as MAP2, TAU, and NEUN, and displayed electrophysio-
logical properties including spontaneous action potentials
and modulation of their activity by glutamate and GABA
neurotransmitters.
Transient expression of the four Yamanaka factors has
been used as alternative approach to generate iNPCs (Kim
et al., 2011; Lu et al., 2013; Thier et al., 2012). However,
the presence of pluripotent intermediate cell types could
not be excluded in those studies and the protocols were
laborious and time consuming. In this regard, our study
represents a technical advance for the fast and efﬁcient
generation of human integration-free iNCs, without forc-
ing the cells to ﬁrst go back to an intermediate pluripotent
stage (Mitchell et al., 2014). Noteworthy, iNPCs have been
recently obtained from mouse ﬁbroblasts using small mol-
ecules under hypoxia conditions without exogenous tran-
scription factors (Cheng et al., 2014). While these data
represent a safe and attractive strategy for the generation
of neural progenitors, the effectiveness of this approach
on human cells is still unclear. It would be interesting to
assay whether this approach allows lineage conversion of
human hematopoietic cells.
Direct neural conversion from different cell types has
been achieved using the proneurogenic factor ASCL1/
MASH1 (Caiazzo et al., 2011; Karow et al., 2012; Marro
et al., 2011; Pang et al., 2011; Vierbuchen et al., 2010; Wa-
pinski et al., 2013), where it collaborates with BRN2,
MYTL1, and SOX2. Most recently, Wernig’s group demon-
strated that MASH1 alone is sufﬁcient to convert ﬁbroblasts
into iNCs, suggesting that MASH1 is the most important
transcription factor for neural conversion (Chanda et al.,
2014). Intriguingly, we did not observe activation of
MASH1, suggesting that SOX2 activates the neural program
either downstream or independently of MASH1. SOX2 is
expressed during development in self-renewing and multi-
potent neuroepithelial stem cells (Avilion et al., 2003; Ferri
et al., 2004). SOX2 maintains neural progenitor identity
and inhibits neuronal differentiation (Bylund et al., 2003;
Graham et al., 2003). Moreover, in several organs, SOX2-
positive cells display self-renewal and maintain tissue
homeostasis (Arnold et al., 2011). Of note, Cheng et al.
(2014) showed that conversion of mouse ﬁbroblasts into
neural progenitors by inhibition of histone deacetylase
inhibitors, TGF-b, and GSK-3b is accompanied by the acti-
vation of endogenous SOX2 expression. Accordingly, we
observed high and sustained levels of endogenous SOX2
from day 10 of induction and the expression of SOX2
was maintained during propagation of CB-iNCs. These
data are in line with previous works showing that forced
expression of SOX2 alone or in combination with other
transcription factors can convert mouse and human ﬁbro-
blasts into neural stem cells (Ring et al., 2012) or multipo-
tent neural progenitors (Lujan et al., 2012). Noteworthy,
SOX2 and BRN2 have been recently used to convert ﬁbro-
blasts into NPCs (Lujan et al., 2012; Zou et al., 2014).
Furthermore, SOX2 has been shown to co-occupy with
BRN2 (a POU factor) a large set of distal enhancers in
NPCs and regulate together a subset of genes important
for neural fate (Lodato et al., 2013; Miyagi et al., 2006).
Consistent with these data we observed the induction of
endogenous BRN2 in our CB-iNCs during the conversion
process. Based on these ﬁndings, it is tempting to speculate
that SOX2 with c-MYC initiate the neural conversion of
blood cells and then SOX2 and BRN2 cooperate to drive
the CB-iNCs toward neuronal linages.
Figure 3. In Vitro Neuronal Differentiation and Whole-Cell Patch-Clamp Recordings of CB-iNCs
(A) Representative phase contrast (a) and immunoﬂuorescence (b–i) images of CB-iNCs at differentiation day 65. Differentiated CB-iNCs
expressed postmitotic mature markers such as axonal speciﬁc neuroﬁlament SMI 312 (NF), MAP2, TAU (T46 epitope), and NEUN (RBFOX3)
(b–e). (d) High-magniﬁcation image of TAU-positive cells showing downregulation of SOX2 nuclear staining, indicated by white arrows.
CB-iNCs can differentiate into inhibitory GABA-positive neurons (e) and excitatory vGLUT1-positive neurons (f). Mature neurons derived
from CB-iNCs after 65 days of differentiation expressed synaptic proteins, such as SYN and SV2 (g–i). Scale bars are as indicated in the
panels.
(B) Current-clamp recordings from a GFP-positive (SYN::GFP) cell showing evoked action potentials by injecting 20 pA current steps
(middle panel) and spontaneous action potentials at a  40 mV resting membrane potential (I = 0) (right panel). The scale bar is as
indicated in the panel.
(C) Current-clamp recordings of another GFP-positive (SYN::GFP) cell in the same culture showing spontaneous activity that was phar-
macologically modulated by glutamate (upper right panel) and glutamate antagonists (DNQX: non-NMDA receptor antagonist, MK801:
NMDA receptor antagonist, left and middle bottom panels). Representative traces of spontaneous activity are truncated for clarity.
Immunoﬂuorescence conﬁrmed expression of vGLUT1, together with GFP (SYN::GFP) and human speciﬁc N-CAM in this cell (right bottom
panel). Scale bars are as indicated in the panels.
(D) Spontaneously active cells showed more mature electrophysiological properties, as capacitance was signiﬁcantly higher (t35 = 1.66,
p = 0.05) (left panel) and the resting membrane potential signiﬁcantly lower (t29 = 2.51, p < 0.01) (middle panel) than those recorded
from nonactive cells. Membrane resistance was smaller, although not statistically different (t35 = 1.45, p = 0.07) (right panel). *p % 0.05;
**p < 0.01; unpaired t test.
See also Figure S3.
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Neuronal Conversion of Hematopoietic CellsBased on their in vitro characteristics and gene expres-
sion proﬁle, it is plausible that CB-iNCs contain an ampli-
fyingneuralpopulationthatcanbeexpanded underchem-
ically deﬁned conditions and primed to differentiate into
more committed progenitors. This population presents
similarities with the SOX2-positive cells present in the
neurogenic niches of the adult mammalian brain like the
Nestin
+/ /SOX2
+/GFAP
  in the adult hippocampus and
in the subventricular zone (Codega et al., 2014; Encinas
et al., 2011). These ﬁndings are in agreement with our pre-
vious work and conﬁrm that the coexpression of SOX2 and
c-MYC in CD133-positive CB cells induces direct conver-
sion to neuronal cells at different stages of speciﬁcation
and maturation (Giorgetti et al., 2012). Interestingly,
c-MYC, known to increase the reprogramming efﬁciency
in many systems, has been recently reported to function
as a proneurogenic factor during development promoting
neurogenic cell division (Zinin et al., 2014).
CD133-positive CB cells were easier to reprogram than
PB-MNCs. This was not surprising because CD133-positive
CB cells are young cells expected to carry minimal somatic
mutations, are enriched in highly proliferative primitive
hematopoietic stem/progenitor cells, possess the immuno-
logical immaturity of newborn cells, and have been
previously shown to have a broad differentiation capacity
(Harris, 2009; Ko ¨gler et al., 2004; Rocha et al., 2004).
Interestingly, a recent epigenetic study revealed complete
unmethylation status of promoter/enhancer regions of
SOX2, among other pluripotent genes, in CB stem cells
(Santourlidis et al., 2011). In addition, in some cases, the
SOX2 promoter was found to display the bivalent histone
modiﬁcation typical of pluripotent stem cells (Santourlidis
et al., 2011), suggesting a permissive chromatin organiza-
tion in CB stem cells. In contrast, PB-MNCs are composed
of committed and terminally differentiated cells and are
devoid of stem/progenitor hematopoietic cells. Further-
more, they comprise noncycling, mature immune cells,
which have already undergone complex genetic rearrange-
ments such as T cell and B cell receptor rearrangements
(Zhang, 2013). Thus, our data provide additional evidence
that the cellular context, the cellular ontogeny and very
likely the epigenetic status of the target cells have an
impact on the outcome of the conversion process (Ladewig
et al., 2013). The generation of expandable neuronal popu-
lations from PB cells would be an important step forward
in the production of patient-speciﬁc iNCs for disease
modeling and drug screening interventions. It would be
fascinating to determine whether inhibition of p16
Ink4/
p19
Arf or overexpression of hTERT in PB-MNCs improves
their conversion into neuronal cells. In parallel, further
studies should aim to elucidate the relative contribution
of the exogenous factor combination and the cellular
context determined by the origin and the nature of target
cells.
Finally, there has been recently some concern about SeV
elimination (Yoshioka et al., 2013).
Although our established iNCs rapidly eliminated much
of the SeV, low SeV expression persisted over time as
detected by qRT-PCR. The reason for this is unclear and
possibly involves RNA binding proteins (Iacoangeli
and Tiedge, 2013; Narayanan and Makino, 2013; Scheller
and Dı ´ez, 2009). Nevertheless, in this study, we used a
Figure 4. Generation and Characterization of iNCs from PB-MNCs Using SeV
(A) Schematic representation of neural induction of PB-MNCs. Two hundred ﬁfty thousand PB-MNCs were transduced with SOX2 and c-MYC
SeV vectors at high MOI. At day 1, infected cells were plated on irradiated rat astrocytes in the presence of N2 medium supplemented with
LDN, CHIR99021, and SB431542 compounds. From days 10 to 30, cells were cultured in N2 + B27 medium. From day 30 onward, PB-iNCs
were terminally differentiated in the presence of N2 + B27 medium with BDNF, GDNF, RA, and dbcAMP for another 6–8 weeks.
(B) Representative phase contrast images illustrating the time course of the conversion of PB-MNCs into neural cells. Similar to CB, some
neuroepithelial cells (indicated by white arrows) emerged as early as day 7 (n = 4 independent experiments). Scale bars are as indicated in
the panels.
(C) Representative immunoﬂuorescence images of converted PB-iNCs at days 15 and 30. At day 15, PB-iNCs were DCX positive and showed
an immature morphology; (a) is a confocal orthogonal reconstruction to ensure colocalization with human nuclear antigen HUNU. There
were few Ki67-positive cells (indicated by white arrows) in concordance with the limited expansion capacity (b). By day 30, PB-iNCs
displayed a more mature morphology and expressed TUJ1, axonal speciﬁc neuroﬁlament (NF), and MAP2 (c–e). Scale bars are as indicated
in the panels.
(D) Representative qRT-PCR analysis of early, immature, and mature neuronal markers in PB-MNCs and PB-iNCs after 30 days of neural
induction. Note that expression of these genes was not detected in untransduced PB-MNCs.
(E) PB-iNCs in culture expressing SYN::GFP after lentiviral transduction. GFP-positive cells were patched for electrophysiology. The scale
bar is as indicated in the panel.
(F) Inward Na
+ and outward K
+ voltage-dependent currents triggered upon  70 mV to +50 mV voltage steps (Vh =  50 mV). Na
+ currents
were TTX sensitive. Representative traces of voltage-dependent currents were truncated and expanded for clarity.
(G) PB-iNCs GFP-positive cells showed action potentials evoked by somatic current injection (step 20 pA, n = 15).
(H) No current changes were observed in response to either glutamate or the glutamate receptor antagonist DNQX (Vh =  50 mV).
See also Figure S4.
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upon temperature treatment at 39 C.
In conclusion, we demonstrate a fast and efﬁcient gener-
ation of iNCs from CD133-positive CB cells using noninte-
grative SeV. These CB-iNCs are highly expandable and
can be differentiated under deﬁned culture conditions
into neurons electrophysiologically competent. The short
time course and high reproducibility of our approach
open new avenues for drug screening and toxicity studies.
Our study also underscores the impact of the target cell na-
ture on conversion efﬁciency.
EXPERIMENTAL PROCEDURES
Generation of iNCs from Human Blood Cells
Umbilical CB units (n = 5) were obtained from Hospital Donostia
upon signed informed consent. The project was approved by the
Institutional Review Board of Hospital Donostia. Within 24 hr of
CB collection, CD133-positive cells were isolated as previously
described (Giorgetti et al., 2009); 50,000 CD133-positive cells
were infected with SeV (Life Technologies) encoding the two tran-
scription factors SOX2 and c-MYC (MOI = 3 and MOI = 1.5 respec-
tively). At 24 hr after infection (day 1), fresh CB culture medium
was added. On day 2, infected CD133-positive CB cells were plated
onto primary rat irradiated astrocytes (Lonza) in neural induction
medium([N2(1X)Invitrogen],LDN[500ng/ml;PeproTech],CHIR
[3 mM; Cayman Chemical], SB-431542 [10 mM; Tocris], and FGF2
[20 ng/ml; Invitrogen]). To estimate the efﬁciency of the infection,
 10,000 infected CD133-positive CB cells were used for cytospin
centrifugation and anti-Sendai staining (Anti-SeV 1:500; MBL In-
ternational Corporation) (Table S1). On day 15, cultures contain-
ing CB-iNCs were dissociated with acutase in presence of 5mM
ROCK inhibitor (Y-27632; Tocris) and reseeded on irradiated rat as-
trocytes in the presence of neural expansion medium, including
N2 (1X), B27 (0.5X), BDNF (20 ng/ml; Peprotech), and FGF2
(20 ng/ml). At day 30, CB-iNCs were dissociated and reseeded as
singlecellsonratastrocytesandculturedinNeurobasalmediacon-
taining N2 (1X) and B27 (1X) supplements, 2 mM L-glutamine,
20 ng/ml BDNF, 20 ng/ml glial cell-derived neurotrophic factor
(GDNF), 200 mM ascorbic acid, 0.5 mM dibutyryl cAMP (dbcAMP;
Sigma-Aldrich), and retinoic acid (RA) 20 mg/ml (Sigma-Aldrich).
PB was obtained from healthy volunteers (35–40 years old) upon
informed consent. PB-MNCs were enriched by density gradient
centrifugation, and 250,000 PB-MNCs (n = 4) were infected by
SOX2 and c-MYC SeV (10 and 5 MOI, respectively). At 24 hr after
infection, viral medium was removed, and infected cells were
transferred on rat astrocytes in neural induction medium as
described above. Infection efﬁciency and culture in neural induc-
tion medium was performed as for CD133-positive CB cells.
RNA Puriﬁcation and qRT-PCR
Isolation of total RNA was performed using either RNeasy Mini Kit
(QIAGEN) or RNAqueous-Micro kit (Ambion) based on the cell
number available; 1 mg of RNA was used to synthesize cDNA using
the SuperScript III Reverse Transcriptase kit (Invitrogen). qPCRwas
done using SybrGreen or IDT primetime qPCR assay. Primer
sequencesandprobesusedaredescribedinTableS2andintheSup-
plemental Experimental Procedures.
Immunoﬂuorescence Analysis
Cellswereanalyzedby immunoﬂuorescencestainingas previously
described (Sanchez-Pernaute et al., 2008). Cells cultured on cover-
slips were ﬁxed with 4% paraformaldehyde. Cells were incubated
in blocking buffer: 1 3 PBS with 10% normal donkey serum and
permeabilized with 0.1% Triton X-100 for 1 hr at room tempera-
ture. Stained cells were examined using an LSM510 Meta confocal
microscope equipped with ultraviolet, argon, and helium-neon
lasers (Carl Zeiss) and analyzed using Image J (NIH). Antibodies
and quantiﬁcation methods used are described in Table S1 and
Supplemental Experimental Procedures.
Electrophysiology
For identiﬁcationof induced neurons, cells were transduced with a
lentivirus expressing GFP under the control of the synapsin pro-
moter (SYN::GFP, kindly provided by Dr. Atsushi Miyanohara
[UCSD]) according to previously published protocols (Pruszak
et al., 2007). Glass coverslips were transferred to a recording cham-
ber and perfused with artiﬁcial cerebral spinal ﬂuid (aCSF) solution
containing (in mM) 125 NaCl, 2.5 KCl, 1.2 MgCl2, 26 NaH2CO3,
1.25 NaH2PO4, 2.4 CaCl2, 11 D-glucose saturated with 95% O2,
and 5% CO2 (pH 7.3–7.4, 295–300 mOsm). Neurons were identi-
ﬁed as large green ﬂuorescent cells using a NikonEklipseFN-1 ﬂuo-
rescent microscope. Whole-cell recordings were made at room
temperature using glass pipettes (4–7 MU) pulled with a PC-10
puller (Narishige) and ﬁlled with an internal solution containing
(in mM) 130 potassium gluconate, 5 NaCl, 1 MgCl2, 1 EDTA, 10
HEPES, 2 Mg-ATP, 0.5 Na-GTP, and 10 phosphocreatine (290–295
mOsm). To record whole-cell currents, experiments were carried
out in voltage-clamp mode holding the membrane potential
at  50 mV (Vh =  50 mV). Voltage-dependent currents were
triggered by depolarizing the membrane potential from  70
to +50 mV (300 ms). Spontaneous and evoked action potentials,
induced by injecting current steps from 0 to +120 pA (500 ms),
were recorded in current-clamp mode. Recordings were detected
with a Multiclamp-700B ampliﬁer, ﬁltered at 5 kHz, and digitized
with a Digidata 1440 (Molecular Devices). Data were sampled at
10 kHz with Clampex 10.2 software (Molecular Devices). Tetrodo-
toxin (TTX) (Sigma-Aldrich), glutamate (Research Biochemicals
International), GABA (Abcam Biochemicals) and glutamate antag-
onists MK801, and DNQX (Tocris) were diluted in aCSF and
perfused onto the cultures by gravity ﬂow (1.5–2.0 ml/min).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four ﬁgures, and two tables and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.
2014.10.008.
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